Dr. Maximilien Murone, Chief Operating Officer

Dr. Maximilien Murone

Chief Operating Officer

Maximilien Murone is Chief Operating Officer at Cellestia Biotech AG, Basel, Switzerland. Maximilien holds a Master in Biology (1993), a PhD from the Swiss Institute of Experimental Cancer Research (1997), and an executive MBA from the Faculty of Business and Economics, HEC Lausanne (2016). He has more than 20 years’ experience in operations, business development and project management in various life science companies (biopharma and life science research tools). Most recently, Maximilien served as Associate-Director at Debiopharm International SA, in-licensing new oncology programs (2006 – 2008), and leading the Early Projects team from 2008 to 2015.
LinkedIn Profile


2017 – today
Cellestia Biotech AG, Basel, Switzerland (& Lausanne, Switzerland)
Chief Operating Officer

2016 – 2016
Adipogen SA, Epalinges, Switzerland (& San Diego, CA, USA)
Managing Director

2008 – 2015
Debiopharm SA, Lausanne, Switzerland
Associate-Director, Early Projects

2006 – 2008
Debiopharm SA, Lausanne, Switzerland
Scientific Manager

2002 – 2006
Apotech Corporation SA, Epalinges, Switzerland
Chief Operating Officer

2000 – 2002
The Genetics Company AG, Epalinges, Switzerland (& Zurich, Switzerland)
Research Scientist

1997 – 2000
Genentech, Inc., South San Francisco, CA, USA
Postdoctoral Researcher


2015 – 2016
Executive MBA, University of Lausanne, Switzerland

1993 – 1997
PhD Thesis, Swiss Institute for Experimental Cancer Research, Switzerland

1989 – 1993
Master in Biology, University of Neuchâtel, Switzerland